Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Both backed by phase 3 clinical trial data
This work was supported by the Funds of National Natural Science Foundation of China (82060728), Guizhou Provincial Science and Technology Department (MS [2025-380], Thousand Talents Program), Talents of Guizhou Science and Technology Platform [2021]1350-009, Zunyi Science and Technology Bureau (HZ-2023-173, HZ-2023-09, [2024] No
The random-effect model was used in this meta-analysis
Collectively, these data indicate that GLP-1GIPLani is neither inferior nor superior to its GLP-1RGIPR co-agonist backbone in relation to GLP-1R or GIPR signalling and action
US$ 20.69
US$ 22.17
US$ 22.85
US$ 23.97
US$ 22.03
.png.jpg)
US$ 23.18
US$ 28.83
